Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
![]() |
An Improved Effect Size for Single-Case Research: Nonoverlap of All PairsParker, Richard I ; Vannest, KimberlyBehavior therapy, 2009-12, Vol.40 (4), p.357-367 [Periódico revisado por pares]Amsterdam: Elsevier LtdTexto completo disponível |
2 |
Material Type: Artigo
|
![]() |
Development of monoclonal antibodies against human CYP11B1 and CYP11B2Gomez-Sanchez, Celso E. ; Qi, Xin ; Velarde-Miranda, Carolina ; Plonczynski, Maria W. ; Parker, C. Richard ; Rainey, William ; Satoh, Fumitoshi ; Maekawa, Takashi ; Nakamura, Yasuhiro ; Sasano, Hironobu ; Gomez-Sanchez, Elise P.Molecular and cellular endocrinology, 2014-03, Vol.383 (1-2), p.111-117 [Periódico revisado por pares]Ireland: Elsevier Ireland LtdTexto completo disponível |
3 |
Material Type: Artigo
|
![]() |
Oculoplastic video-based telemedicine consultations: Covid-19 and beyondKang, Swan ; Thomas, Peter B M ; Sim, Dawn A ; Parker, Richard T ; Daniel, Claire ; Uddin, Jimmy MEye (London), 2020-07, Vol.34 (7), p.1193-1195 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
4 |
Material Type: Artigo
|
![]() |
The importance of clinical importance when determining the target difference in sample size calculationsParker, Richard A ; Cook, Jonathan ACurrent controlled trials in cardiovascular medicine, 2023-08, Vol.24 (1), p.495-495, Article 495 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
5 |
Material Type: Artigo
|
![]() |
Response to Letter from Wong on determining the target difference in sample size calculations for randomised controlled trialsCook, Jonathan A ; Parker, Richard ACurrent controlled trials in cardiovascular medicine, 2024-03, Vol.25 (1), p.161-161, Article 161 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
6 |
Material Type: Artigo
|
![]() |
Non-adjustment for multiple testing in multi-arm trials of distinct treatments: Rationale and justificationParker, Richard A ; Weir, Christopher JClinical trials (London, England), 2020-10, Vol.17 (5), p.562-566 [Periódico revisado por pares]London, England: SAGE PublicationsTexto completo disponível |
7 |
Material Type: Artigo
|
![]() |
A mixed method evaluation of a theory based intervention to reduce sedentary behaviour in contact centres- the stand up for health stepped wedge feasibility studySivaramakrishnan, Divya ; Baker, Graham ; Parker, Richard A ; Manner, Jillian ; Lloyd, Scott ; Jepson, Ruth Vega-Muñoz, AlejandroPloS one, 2023-12, Vol.18 (12), p.e0293602-e0293602 [Periódico revisado por pares]United States: Public Library of ScienceTexto completo disponível |
8 |
Material Type: Artigo
|
![]() |
Risk of adverse events including serious infections in rheumatoid arthritis patients treated with tocilizumab: a systematic literature review and meta-analysis of randomized controlled trialsCAMPBELL, Laura ; CHEN CHEN ; BHAGAT, Shweta S ; PARKER, Richard A ; ÖSTÖR, Andrew J. KRheumatology (Oxford, England), 2011-03, Vol.50 (3), p.552-562 [Periódico revisado por pares]Oxford: Oxford University PressTexto completo disponível |
9 |
Material Type: Artigo
|
![]() |
Multiple secondary outcome analyses: precise interpretation is importantParker, Richard A ; Weir, Christopher JCurrent controlled trials in cardiovascular medicine, 2022-01, Vol.23 (1), p.27-27, Article 27 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |
10 |
Material Type: Artigo
|
![]() |
First-time traumatic patellar dislocation: a systematic reviewStefancin, John J ; Parker, Richard DClinical orthopaedics and related research, 2007-02, Vol.455, p.93-101 [Periódico revisado por pares]United StatesSem texto completo |